Did You Know?
ICH E6(R2) regulations dictate sponsors must ensure oversight of any trial-related duties and functions,
even when trials are outsourced to CROs.
Failure to comply with regulatory responsibilities can result in critical findings, slowing trials and increasing costs.
Is your organization compliant with ICH E6(R2)?
Get the Fact Sheet
Inadequate review documentation when monitoring visit reports (MVRs) were created by CROs
Lack of review for protocol deviations
No evidence to demonstrate compliance with oversight activities and how the trial was conducted
Less Risk, More Confidence in Outsourced Trials
Effectively demonstrating study oversight ensures compliance with global regulations and gives you confidence in the integrity of your trials. A modern CTMS provides real-time visibility and oversight, reducing compliance risk and elevating confidence that trials are high-quality and run to the highest standards.